Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v6-EN
Language French English
Date Updated 2017-11-03 2017-04-25
Drug Identification Number 02446073 02446073
Brand name ISMN ISMN
Common or Proper name ISMN ISMN
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients ISOSORBIDE-5-MONONITRATE ISOSORBIDE-5-MONONITRATE
Strength(s) 60MG 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C01DA C01DA
ATC description VASODILATORS USED IN CARDIAC DISEASES VASODILATORS USED IN CARDIAC DISEASES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-04-25 2017-04-25
Actual start date
Estimated end date Unknown
Actual end date 2017-06-27 2017-04-24
Shortage status Resolved Avoided shortage
Tier 3 Status No No
Company comments Moved into discontinuation section
Health Canada comments